Recruiting Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT04422366 Conditions AIS, CIN1, CIN2, +45 more Locations Liuzhou center for disease control and prevention — Liuzhou, Guangxi, China View Trial Details
Completed Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT05372016 Conditions AIS, CIN1, CIN2, +46 more Locations Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention — Guangxi, China View Trial Details
Completed Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT04425291 Conditions AIS, CIN1, CIN2, +45 more Locations Yangchun Center For Disease Prevention And Control — Yangchun, Guangdong, China View Trial Details
Completed Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT03676101 Conditions AIS, CIN 3, CIN1, +46 more Locations Zhejiang Provincial Center for Disease Control and Prevention — Hanzhou, China View Trial Details
